澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

MESOBLAST LTD

2.395

+0.0351.48%

成交量：151.30万

成交额：364.33万

市值：31.06亿

市盈率：-23.38

高：2.460

开：2.380

低：2.340

收：2.360

52周最高：3.310

52周最低：1.880

股本：12.97亿

流通股本：7.86亿

量比：1.11

换手率：0.19%

股息：- -

股息率：- -

每股收益(TTM):-0.102

每股收益(LYR):-0.118

净资产收益率：-18.22%

总资产收益率：-6.16%

市净率：3.88

市盈率(LYR):-20.34

数据加载中...

总览公司新闻资讯公告

概念

新冠治疗股-1.19%

医药生物股+0.12%

资金流向

资金流入：

资金流出：

新闻资讯

Mesoblast Limited：预计短期内将持续面临重大亏损

Mesoblast完成慢性腰痛关键性3期试验患者治疗，达成重大里程碑

Mesoblast报告Ryoncil®季度净营收3600万美元，产品上市首年净营收达1.15亿美元

Mesoblast首席执行官增持股份以强化股权

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/hans/stock/MSB.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MSB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","market":"AU","secType":"STK","nameCN":"MESOBLAST LTD","latestPrice":2.395,"timestamp":1787799988968,"preClose":2.36,"halted":0,"volume":1512997,"delay":0,"changeRate":0.014830508474576332,"nameEN":"MESOBLAST LTD","floatShares":786490638,"shares":1296862776,"eps":-0.10244868864007842,"marketStatus":"交易中","change":0.035,"latestTime":"08-27 13:06:38 AEST","open":2.38,"high":2.46,"low":2.34,"amount":3643317,"amplitude":0.050847,"askPrice":2.4,"askSize":17987,"bidPrice":2.39,"bidSize":18184,"shortable":3,"etf":0,"ttmEps":-0.10244868864007842,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1787810400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":2.36,"openAndCloseTimeList":[[1787788800000,1787810400000]],"volumeRatio":1.105494,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MSB.AU","preClose":2.36,"auctionPrice":2.38,"auctionVolume":89243,"auctionTime":1787788750345,"referenceTime":1787740203093,"auction":1,"marketStatus":"盘前竞价","timestamp":1787788750345}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","floatShares":786490638,"roa":"-6.16%","roe":"-18.22%","lyrEps":-0.117741,"volumeRatio":1.105494,"shares":1296862776,"dividePrice":0,"high":2.46,"amplitude":0.050847,"preClose":2.36,"low":2.34,"week52Low":1.88,"pbRate":"3.88","psRate":"34.12","week52High":3.31,"institutionHeld":0,"latestPrice":2.395,"committee":0.005446,"eps":-0.10244868864007842,"divideRate":0,"volume":1512997,"delay":0,"ttmEps":-0.10244868864007842,"open":2.38,"prevYearClose":2.72,"prevWeekClose":2.36,"prevMonthClose":2.05,"prevQuarterClose":1.955,"fiveDayClose":2.51,"twentyDayClose":2.04,"sixtyDayClose":2.02,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSB.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"MSB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787702400000,"name":null,"time":"","dateTimestamp":1787666400000,"actualEps":null},{"date":"2025-02-26","symbol":"MSB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MSB.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1198020721","title":"Mesoblast Limited：预计短期内将持续面临重大亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=1198020721","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198020721?lang=zh_cn&edition=fundamental","pubTime":"2026-08-27 06:27","pubTimestamp":1787783223,"startTime":"0","endTime":"0","summary":"Mesoblast Limited近日发出预警，表明公司可能在未来可预见的一段时期内，继续承受显著的财务亏损。Mesoblast在研发上的持续投入，虽然从长远来看可能带来丰厚回报，但短期内却不可避免地加重了其财务负担。在当前生物科技板块波动加剧的背景下，Mesoblast的这一声明或将引发市场对其未来融资策略和现金流状况的更多关注。Mesoblast能否在亏损泥潭中找到突破口，市场正拭目以待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","MSB.AU","BK4139","MESO","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176396021","title":"Mesoblast完成慢性腰痛关键性3期试验患者治疗，达成重大里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1176396021","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176396021?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 08:36","pubTimestamp":1786926968,"startTime":"0","endTime":"0","summary":"Mesoblast（MESOBLAST LTD）在治疗慢性腰痛的关键性3期临床试验中，已顺利完成全部患者的治疗工作。这一成就标志着该公司在推进这一潜在疗法上迈出了决定性的一步。临床试验的完成，不仅为后续的数据分析铺平了道路，也极大地提振了市场对这款创新疗法的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7508","BK7067","MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134208248","title":"Mesoblast报告Ryoncil®季度净营收3600万美元，产品上市首年净营收达1.15亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134208248","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134208248?lang=zh_cn&edition=fundamental","pubTime":"2026-07-30 08:59","pubTimestamp":1785373168,"startTime":"0","endTime":"0","summary":"Mesoblast（股票代码：MSB.AU）公布了其核心产品Ryoncil®的财务表现。数据显示，该公司在最近一个季度录得净营收3600万美元（约合3600万美元）。不仅如此，从产品正式上市至今的第一个完整财年内，Ryoncil®累计贡献的净营收总额已达到1.15亿美元。这一成绩标志着该产品在商业化初期便展现出强劲的市场接纳度与增长潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB.AU","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157804936","title":"Mesoblast首席执行官增持股份以强化股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1157804936","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157804936?lang=zh_cn&edition=fundamental","pubTime":"2026-07-21 09:53","pubTimestamp":1784598831,"startTime":"0","endTime":"0","summary":"Mesoblast Ltd宣布，其首席执行官已通过投资进一步增持公司股份。具体而言，该首席执行官行使了190万份股票期权，行权价为每股1.45澳元，总价值达273万澳元。此次交易后，其持股总数增加至8080万股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","BK7501","MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MSB.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"新冠治疗股","id":"package_au_concept_xgzlg","bkCode":"BK7501","changeRate":-0.011878},{"market":"AU","name":"医药生物股","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.001154}]}}